Concepedia

Matthew Yates

MY

10

Publications

593

Citations

10

H-Index

2009

Active since

Affiliations

Pfizer (United States)(Current)

Saint Louis University

Matthew Yates is an author at Pfizer (United States) specializing in medicine, pharmacology, and cancer research.

Top concepts

Publications per year

2009–2017

10

Publications

10

Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1

Mark E. Schnute, Matthew D. McReynolds, Tom Kasten et al. · Biochemical Journal · 2012 · 274 citations

, , +20

BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells

Amy E. Campbell, Jonathan Oliva, Matthew Yates et al. · Skeletal Muscle · 2017 · 63 citations · Full text

Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening Hits

Mark E. Schnute, Matthew D. McReynolds, Jeffrey Carroll et al. · Journal of Medicinal Chemistry · 2017 · 52 citations · Full text

ADAM‐8 isolated from human osteoarthritic chondrocytes cleaves fibronectin at Ala<sup>271</sup>

Marc D. Zack, Anne‐Marie Malfait, Adam Skepner et al. · Arthritis & Rheumatism · 2009 · 49 citations

H‐ficolin binds <i><scp>A</scp>spergillus fumigatus</i> leading to activation of the lectin complement pathway and modulation of lung epithelial immune responses

Stefan Bidula, Darren W. Sexton, Matthew Yates et al. · Immunology · 2015 · 42 citations · Full text

Rows per page

1–5 of 10